MIRA Similar Chart Price Prediction
The price of MIRA is predicted to go up 3.98%, based on the high correlation periods with WAB. The similarity of these two price pattern on the periods is 95.73%.
MIRA
WAB
Up: 3.98%Similarity: 95.73%
MIRA Revenue Forecast
MIRA EPS Forecast
MIRA FAQs
What is MIRA eps forecast for next quarter？
MIRA Analyst's Forecast
Elemer Piros
Rodman & Renshaw
Strong Buy
2024-09-30
Price Target
$17
Downside
0%
Rodman & Renshaw analyst Elemer Piros initiated coverage of Mira Pharmaceuticals with a Buy rating and $17 price target. Mira is developing next-generation, orally available ketamine and medicinal marijuana derivatives, notes the analyst, whose Buy thesis is based on the firm's view of the potential future cash flows from the company's Ketamir-2 program and its assessment of the probability of its success.
